Drug profile · INN
afatinib
GIOTRIF
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
afatinib (GIOTRIF) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN afatinib
Brand GIOTRIF
Route ORAL
Formulation TABLET
ATC code L01XE13
Frequently asked questions
What is afatinib?
afatinib (GIOTRIF) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for afatinib?
GIOTRIF is a marketed brand name for afatinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of afatinib?
afatinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.